BVA-100

BVA-100

A semi-automated device which measures blood volume, providing results in 25–35 minutes with ±2% error.
References in periodicals archive ?
DORO, which conducts Daxor's equipment manufacturing, testing and development for the Blood Volume Analyzer BVA-100, will be moving into its new facilities to accommodate its existing operations and planned future research projects.
Among nationally renowned hospitals and other major medical institutions which have purchased the BVA-100 Blood Volume Analyzer after a trial period are the Mayo Clinic, The Cleveland Clinic, NIH, and New York University Medical Center.
Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer.
The Blood Volume Analyzer BVA-100 will be located in the Hospital's Nuclear Medicine Department to diagnose blood volume derangements in hematology, cardiology and critical care.
Daxor's BVA-100 will be located within Lenox Hill Hospital's Nuclear Medicine Department.
Daxor's BVA-100 will be located within Allegheny's Nuclear Cardiology Department.
The company provides the BVA-100 Blood Volume Analyzer on a trial basis with an option to purchase.
DaxoreIUs Blood Volume Analyzer BVA-100 will be located within the University HospitaleIUs Nuclear Medicine Department.
Queen's Medical Center, which purchased its first BVA-100 following a trial agreement, utilized blood volume measurements for various clinical applications.
The BVA-100 will be located in the Nuclear Medicine Department, which will provide Blood Volume Analysis to physicians in Hematology, Cardiology and Critical Care.
Recent BVA-100 data presented at the 2006 Heart Failure Society of America by Columbia University Medical Center, demonstrated that 92% of patients who are diagnosed as having diastolic or "right-sided" heart failure are anemic rather than volume overloaded and hemodiluted.